RAPS: FDA Wants Input on How to Improve Clinical Trials Process for Industry

The US Food and Drug Administration (FDA) wants the public\'s feedback on ways it can make it easier to communicate with the agency during the clinical trials process. In an announcement in the Federal Register on 28 October 2014, FDA said it had established a docket at regulations.gov to allow it to receive comments from industry, the public and other organizations interested in formulating \"best practices for communication between FDA and investigational new drug application (IND) sponsors during drug development.\"